Trials / Completed
CompletedNCT03801486
Effects of Incorporating Sprouted and Non-sprouted Chickpea Flour in Pasta Products Analyzed in Vivo Flow-mediated Dilation
The Effects of Incorporating Sprouted and Non-sprouted Chickpea Flour in Pasta Products Analyzed in Vivo Flow-mediated Dilation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 34 (actual)
- Sponsor
- Montclair State University · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The investigators examined the effects on post-digestion brachial artery flow mediated dilation (FMD) and in vitro antioxidant capacity of 40% semolina flour replacement with sprouted chickpea flour.
Detailed description
The purpose of the current study was to examine in-vitro and in-vivo effects of replacing 40% of semolina flour with sprouted chickpea flour for the use in pasta. Antioxidant capacity in-vitro was measured by Trolox Equivalent Antioxidant Capacity. Brachial artery flow-mediated dilation, a test of in-vivo endothelial function, was performed for assessment of effects on post-digestion endothelial function. The investigators hypothesized that FMD would be higher after consuming 40% of semolina flour with sprouted chickpea flour pasta vs. 100% of semolina flour pasta.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Experimental: Sprouted Chickpea Flour | 255g of pasta with 40% sprouted chickpea flour and 60% semolina flour (SCF40) with butter. |
| OTHER | Control: Semolina Flour | 255g of pasta with 100% semolina flour (SEM100) with butter. |
Timeline
- Start date
- 2016-03-02
- Primary completion
- 2017-05-01
- Completion
- 2017-05-01
- First posted
- 2019-01-11
- Last updated
- 2023-10-30
Source: ClinicalTrials.gov record NCT03801486. Inclusion in this directory is not an endorsement.